CD4+ lymphopenia is key in the clinical evolution of HIV patients [23–25], is common in many advanced cancer patients with pancreatic cancer, melanoma, NHL, BC, sarcomas or hepatocellular carcinoma (HCC) [19–21]. Here, CD4 is linked to breast cancer.